Can environmental factors predispose noncommunicable diseases?

Open Nutraceuticals Journal

Volumn 4, Issue SPEC.ISS.1, 2011, Pages 45-51

  Sergey, Chibisov ^a   Agarval, Radjhesh ^b   Singh, R B ^c   Wilzynsca, Agnieska ^c   De Meester, Fabien ^c  

^a PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^b Network of World Doctors   (Russian Federation)

^c Tsim Tsoum Institute   (Poland)

Author keywords

Chronic diseases; Diet; Heliomagnetic fluctuations; Inflammation; Lifestyle; Noncommunicalbe diseases

Indexed keywords

EID: 84861847127     PISSN: None     EISSN: 18763960     Source Type: Journal    
DOI: 10.2174/1876396001104010045     Document Type: Article

References (57)

1. World Health Organization. Preventing Chronic Disease: A Vital Investment World Heath Organization, Geneva, 2005.
2. Joint WHO/FAO Expert Consultation. Diet, Nutrition and the Prevention of Chronic Diseases, WHO, Geneva, WHO Technical Report Series, 916, 2003.
3. WHO Study Group. Diet, Nutrition and Prevention of Chronic Diseases, WHO, Geneva, 1990.
4. World Health Organization. Diet and Physical Activity: a public Health Priority. World Health Organization, http:/www.who. int/diet physical activity/en/ [accessed 2009].
5. World Health Organization. WHO framework convention on tobacco control. Available at: http:/www.whoint/tobacco/framework/ en/ [Accessed 2009].
6. Singh RB, Pella D, Mechirova V, et al. Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group. Acta Cardiol 2007; 62: 119-27.
7. Chibisov SM, Vishnevsky VV, Ragulskaya MV. Telecommunication monitoring is a method for studies of the effect of heliomagnetic fluctuations on cardiac function. Bull Exp Biol Med 2008; 143: 765-8.
8. Singh RB, Singh V, Kulshrestha SK, et al. Social class and all cause mortality in the urban population of north India. Acta Cardiol 2005; 60: 611-7.
9. Singh RB, DeMeester F, Mechirova V, Pella D, Otsuka K. Fatty acids in the causation and therapy of metabolic syndrome. In Wild Type Foods in Health Promotion and Disease Prevention, editors Fabien De Meester and RR Watson, Humana Press, NJ 2008, pp. 263-284.
10. Singh RB, IL Suh, VP Singh, S Chaithiraphan, P Laothavorn, RG Sy, NA Babilonia, ARA Rahman, S Sheikh, B Tomlinsin and N Sarraf-Zadigan. Hypertension and stroke in Asia: prevelance, control and strategies in developing countries for prevention. J Human Hyper 2000; 14: 749-63.
11. American Heart Association Heart and Stroke Statistical Update, 2008. http://www.americanheart.org/downloadable/heart/ 1200078608862HS Stats%202008.final.pdf
12. Singh RB, Beegom R, Mehta AS, et al., Social class and coronary risk factors and undernutrition: a double burden of diseases among women in five Indian cities. Int J Cardiol 1999; 353: 154-65.
13. Simopoulos AP. Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. World Rev Nutr Diet 2003; 92: 1-22.
14. De Meester F, Wild-type land based foods in health promotion and disease prevention: the LDL-CC:HDL-CC model. In Wild Type Foods in Health Promotion and Disease Prevention, editors Fabien DeMeester and RR Watson, Humana Press, NJ 2008, pp. 3-20.
15. Vogel RA. 21. Eating vascular biology and atherosclerosis: a lot to chew on. Eur Heart J 2006; 27: 13-4.
16. Esposito K, Giugiliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 2006; 27: 15-20.
17. Kelishadi R, Mirghaffari N, Poursafa, P Gidding SS. Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children. Atherosclerosis 2009; 203: 311-9
18. Simopoulos AP. Is Insulin Resistance Influenced by Dietary Linoleic Acid and Trans Fatty Acids? Free Radic Biol Med 1994; 17; 367-72.
19. Simopolous AP. Genetic variation and dietary response: nutrigenetics/nutrigenomics. Asia Pac J Clin Nutr 2002; 11: S117-28.
20. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002; 18: 430-8.
21. Ridker PM, Danieison E, Fonseka FAH, et al. Reduction in Creactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009; 373: 1175-82.
22. Trichopolou A, Bamia C, Trichopolou D. Anatomy of health effects of Mediterranean diet. Greek EPIC prospective cohort study. BMJ 2009; 338: b2337.
23. Singh RB, De Meester F, Pella D, Basu TK, Watson R. Globalization of dietary wild foods protect against cardiovascular disease and all cause mortalities? A Scientific statement from the International College of Cardiology, Columbus Paradigm Institute and the International College of Nutrition. Open Nutra J 2009; 2: 42-5.
24. Eaton SB, Eaton SB III, Sinclair AJ, Cordain I, Mann NJ. Dietary intake of long chain polyunsaturated fatty acids during the Paleilithic period. In Simopoulos AP edition. The return of w-3 fatty acids in the food supply. Land based Animal Food Products and their Health Effects. World Rev Nutr Dietetics 1998; 83: 12-23.
25. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-9. Erratum in: Lancet 1995; 345:738.
26. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr 1995; 61(6 Suppl): 1360S-7S.
27. Singh RB, Gupta A, Pella D, Kumar A. Circadian Cardiology. World Heart J 2008; 1: 101-26.
28. Dubnov Gal, Pella D, Singh RB. The effect of an alpha-linolenic acid rich diet on the circadian rhythm of cardiac events. World Heart J 2008; 1: 49-56.
29. Labrador MP, Polk D, Dwyer JH, et al. Effects of randomized, controlled trial of Transcendental meditation on components of metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006; 166: 1218-24.
30. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88: 119-24.
31. Rodriguez T, Malvezzi M, Chatenoud L, et al. Trends in mortality from coronary heart and cerebrovascular diseases in Americas: 1970-2000. Heart 2006; 92: 453-60.
32. Raymond SU, Greenberg HM, Leeder SR. Beyond reproduction: women's health in todays developing world. Int J Epidemiol 2005; 34: 1144-8.
33. Leader SR, Raymond SU, Greenberg HM, Hui L, Esson KA Race Against Time: The Challenge of Cardiovascular Disease in Developing Economies. New York, NY: Columbia University; 2004.
34. Gillum RF. The epidemiological evolution in pattern of cardiovascular diseases in blacks. N Engl J Med 1996; 335: 1597-9.
35. World Bank. Invest in Health. World Development Report 1993, Oxford, Oxford University Press, 1993; 195-324.
36. World Health Organization. The 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases (Action Plan http://www.who.int/nmh/Actionplan-PCNCD-2008.pdf
37. Beaglehole R, Reddy S, Leeder SR. Poverty and human development. The global implications of cardiovascular disease (Editorial). Circulation 2007; 116: 1871-3.
38. Fuster V, Voute J, MDGs: Chronic diseases are not on the agenda. Lancet 2005; 366: 1512-4.
39. Moreno P, Sanz J, Fuster V. Promoting mechanisms of vascular health. J Am Coll Cardiol 2009; 53: 2315-23.
40. Razzouk L, Farkouh ME. Imaging outcomes in cardiovascular clinical trials. Nat Rev Cardiol 2009; 6: 524-31.
41. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives we can save? Lancet 2005; 366: 1578-82.
42. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet 2005; 366: 1821-4.
43. nd edition, New York, Oxford University Press/World University Press/World Bank; 2006.
44. Mesle F. Mortality in Central and Eastern Europe: long-term trends and recent upturns. Demogr Res 2004; 2: 45-70.
45. Boylan S, Welch A, Pikhart H, et al. Dietary habits in three Central and Eastern European countries: the HAPIEE study. BMC Pub Health 2009; 9: 439-45.
46. Singh RB, Cornelissen G, Weydahl A et al. Circadian heart rate and blood pressure variability considered for research and patient care. Int J Cardiol 2003; 87: 9-28.
47. Sundaram B, Holley DC, Cornelissen G, et al. Circadian and circaseptan (about weekly) aspects of immigrant Indians blood pressures and heart rate in California, USA. Biomed Pharmacol 2005; 59: S76-85.
48. Cornélissen, G, Halberg F, Otsuka K, Singh RB, Chen CH. Chronobiology predicts Actual and proxy outcomes when dipping fails. Hypertension 2007; 49: 237-9.
49. Halberg F, Cornélissen G, Ulmer W, et al. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol 2006; 6: 73-84.
50. Halberg F, Cornélissen G, Otsuka K, et al. Extended consensus on need and means to detect vascular variability disorders (vvds) and vascular variability syndromes (vvss). Int J Gerontol Chronome Geriatr 2008; 11: 119-46.
51. Ragulskaya MV, Pipin VV, Chibisov SM. The dynamical properties of the human EGC in the light of tele-communicational heliomedical monitoring("Heliomed") People's Friendship University Chronobiology Chronomedicine Symposium, Moscow, Feb 7, 2010.
52. Pednekar MS, Gupta R, Gupta PC. Association of blood pressure and cardiovascular mortality in India: Mumbai Cohort Study. Am J Hypertens 2009; 22(10): 1076-84.
53. Paoletti R. Nutrition and noncommunicale diseases. www. healtheurope.org [Accessed December 17, 2009].
54. Nanda S, Mishra S, Varshney VP, Singh RB. A Biotechnological Approach to Apoptosis of Somatic and Germ Cells in Living Organisms. Open Nutra J 2010; 3: 81-93.
55. Mudgal V, Madaan N, Mudgal A, Singh RB, Mishra S. Effect of Toxic Metals on Human Health. Open Nutra J 2010; 3: 94-9.
56. Nanda S, Mishra S, Varshney VP, Tyagi A, Singh RB. Cytotoxic Effect of Syzgium aromaticum Extract and Gemcitabine on Human Cervical Cancer Cell Line. Open Nutra J 2010; 3: 69-75.
57. Sharma V, Kalim S, Srivastava MK, Nanda S, Mishra S. Oxidative stress and coxsackievirus infections as mediators of beta cell damage: A review. Sci Res Essays 2009; 4(2): 42-58.